Brief: Leading Institutions Enroll First Alzheimer’s Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study
17/04/2024 14:21
April 17 (Reuters) - Hyperfine Inc HYPR.O :
* LEADING INSTITUTIONS ENROLL FIRST ALZHEIMER’S PATIENTS
RECEIVING
AMYLOID-TARGETING THERAPY IN CARE PMR STUDY
Source text for Eikon: ID:nBw2cDpxqa
Further company coverage: HYPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hyperfine
See all newsBrief: Hyperfine Inc - Files To Register Up To 1.2 Million Shares Of Class A Common Stock By Selling Securityholders - SEC Filing
Hyperfine Q1 revenue rises as commercial engine accelerates
Brief: Hyperfine, Inc. Q1 EPS USD -0.09
Brief: Horizon Technology Finance Provides $40 Million Loan Facility To Hyperfine
Brief: Hyperfine Enters Loan And Security Agreement With Horizon Technology Finance - SEC Filing